Aspirin in the Form of Microneedle Repairs DNA and Reduces Inflammation in Persistent Skin Damage.


Journal

Biomaterials research
ISSN: 1226-4601
Titre abrégé: Biomater Res
Pays: United States
ID NLM: 101650636

Informations de publication

Date de publication:
2024
Historique:
received: 06 06 2024
revised: 11 08 2024
accepted: 26 08 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 17 9 2024
Statut: epublish

Résumé

Skin damage caused by chemical corrosion is currently one of the common skin diseases and poisoning symptoms, with nitrogen mustard compounds causing the most persistent and severe damage. These chemicals penetrate the top layer of the skin, enter the dermis, and cause DNA damage, oxidative stress, and inflammation. However, to date, no effective drug treatment has been found. Even the potential antidotes could not effectively penetrate the top layer of the skin to exert their effects due to the skin barrier. To address this problem, an innovative transdermal drug delivery strategy based on aspirin microneedles was proposed. The classic medicine aspirin was first discovered not only to reduce inflammation and oxidative stress but also to promote DNA repair and reduce DNA damage. The aspirin microneedles directly delivered the drug to the damaged area, released aspirin through the skin barrier, and exhibited good biocompatibility. These findings indicate that aspirin microneedles have great potential for promoting wound healing and broad application prospects.

Identifiants

pubmed: 39286542
doi: 10.34133/bmr.0083
pii: 0083
pmc: PMC11403356
doi:

Types de publication

Journal Article

Langues

eng

Pagination

0083

Informations de copyright

Copyright © 2024 Wenbin Cao et al.

Déclaration de conflit d'intérêts

Competing interests: The authors declare that they have no competing interests.

Auteurs

Wenbin Cao (W)

State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institutes of Pharmacology and Toxicology, Beijing 100850, China.

Huanchun Xing (H)

State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institutes of Pharmacology and Toxicology, Beijing 100850, China.
Tianjin University of Science and Technology, Tianjin 300222, China.

Shuai Guo (S)

State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institutes of Pharmacology and Toxicology, Beijing 100850, China.
Hebei University of Science and Technology, Shijiazhuang 050018, China.

Lin Wang (L)

State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institutes of Pharmacology and Toxicology, Beijing 100850, China.

Xin Sui (X)

State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institutes of Pharmacology and Toxicology, Beijing 100850, China.

Lijuan Huang (L)

State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institutes of Pharmacology and Toxicology, Beijing 100850, China.
Department of Bacteriology, Capital Institute of Pediatrics, Beijing 100020, China.

Yuan Luo (Y)

State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institutes of Pharmacology and Toxicology, Beijing 100850, China.

Jun Yang (J)

State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institutes of Pharmacology and Toxicology, Beijing 100850, China.

Yongan Wang (Y)

State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institutes of Pharmacology and Toxicology, Beijing 100850, China.

Classifications MeSH